Semaglutide supplies return to Australia ahead of schedule Limited quantities of the medication will be available from late next week, the TGA has said, but GPs have been asked to not prescribe it off-label.
‘The virus has evolved’: Fifth COVID dose available soon Adults will become eligible for a fifth dose from 20 February, supported by a new incentive for GPs attending aged care and disability facilities.
Concerns over growing misuse of Rikodeine cough medicine The addictive cough suppressant is popular among young people, more potent than codeine, and poses a serious risk of harm.
What does clutter do to your brain and body? An expert in organisational behaviour examines the effects disorganisation.
Shingrix to replace Zostavax on the National Immunisation Program The news has been welcomed by the Immunisation Coalition, but there are also concerns about eligibility restrictions.
What GPs need to know about the new COVID antivirals Both oral antiviral COVID-19 treatments are now available, with significant restrictions, on the PBS.
Semaglutide unavailable in Australia until April 2023 GPs have been told not to initiate any new patients on either semaglutide or dulaglutide, which will also only have ‘limited availability’.
One of the many faces of codeine addiction Jessica Khachan lives in Sydney with her husband and two kids, who are 14 and 12, in what she describes as ‘a normal suburban household’. She is also one of the increasing number of Australians with a history of codeine addiction.
Why do some people infected with COVID-19 lose their smell? New research suggests there may be a genetic link in people who experience anosmia with COVID infection.
Which July Medicare changes will impact GPs? With the new financial year almost upon us, newsGP sums up the key changes to MBS item numbers from the beginning of next month.